Gs Investments, Inc. Nektar Therapeutics Transaction History

Gs Investments, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$4.16 - $13.72 $83,200 - $274,400	-20,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $261,400 - $376,800	20,000 New	20,000 $359,000
Q1 2021 May 07, 2021	SELL	$16.56 - $25.46 $312,984 - $481,194	-18,900 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$15.77 - $19.03 $298,053 - $359,667	18,900 New	18,900 $321,000
Q3 2020 Nov 12, 2020	SELL	$16.59 - $24.79 $899,178 - $1.34 Million	-54,200 Closed	0 $0

Q1 2020 May 07, 2020	BUY	$14.47 - $27.96 $4,341 - $8,388	300 Added 0.56%	54,200 $967 Million
Q4 2019 Feb 04, 2020	SELL	$15.87 - $23.12 $4,761 - $6,936	-300 Reduced 0.55%	53,900 $2.63 Billion
Q1 2019 Apr 26, 2019	BUY	$31.58 - $46.35 $6,316 - $9,270	200 Added 0.37%	54,200 $1.82 Billion
Q2 2018 Aug 10, 2018	BUY	$46.25 - $104.45 $92,500 - $208,900	2,000 Added 3.85%	54,000 $2.64 Billion
Q1 2018 May 15, 2018	SELL	$57.4 - $108.44 $273,224 - $516,174	-4,760 Reduced 8.39%	52,000 $5.53 Billion
Q4 2017 Feb 13, 2018	SELL	$23.02 - $60.5 $1,151 - $3,025	-50 Reduced 0.09%	56,760 $3.39 Billion
Q3 2017 Nov 07, 2017	BUY	$17.79 - $24.0 $95,176 - $128,400	5,350 Added 10.4%	56,810 $1.36 Billion
Q2 2017 Aug 29, 2017	BUY	N/A	51,460	51,460 $1.01 Billion

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $242M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Gs Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Gs Investments, Inc. with notifications on news.